Induced Pluripotent Stem Cells from Individuals with Recessive Dystrophic Epidermolysis Bullosa-Reference-Cited by-同舟云学术

Induced Pluripotent Stem Cells from Individuals with Recessive Dystrophic Epidermolysis Bullosa

Published:2011-04 Issue:4 Volume:131 Page:848-856
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Tolar Jakub,Xia Lily,Riddle Megan J.,Lees Chris J.,Eide Cindy R.,McElmurry Ron T.,Titeux Matthias,Osborn Mark J.,Lund Troy C.,Hovnanian Alain,Wagner John E.,Blazar Bruce R.

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference39 articles.

1. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes;Aasen;Nat Biotechnol,2008

2. Recessive dystrophic epidermolysis bullosa. Part 2: care of the adult patient;Abercrombie;Br J Nurs,2008

3. Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa;Chen;Nat Genet,2002

4. Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fibroblasts to the skin and inducing immune tolerance;Chino;Am J Pathol,2008

5. Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa;Conget;Cytotherapy,2010

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stem Cell Therapies for Epidermolysis Bullosa Treatment;Bioengineering;2023-03-27

2. New Prospects in Skin Tissue Engineering and Fabrication;Biofabrication for Orthopedics;2022-09-30

3. Revertant Mosaicism in Genodermatoses: Natural Gene Therapy Right before Your Eyes;Biomedicines;2022-08-29

4. Generation and characterization of hair-bearing skin organoids from human pluripotent stem cells;Nature Protocols;2022-03-23

5. Stem Cells in Wound Healing and Scarring;Handbook of Stem Cell Therapy;2022